← Leaderboards
Connor O'Brien
Stanford University
$125,662
Attributed
$125,662
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $63.1K · FY2017–18$100K$75K$50K$25K$0
'17
'18
Funding mix
By agency
NIH$125,662 · 1
By mechanism
F32$125,662 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Joseph C Wu$80,370,369
- Paul W. Burridge$6,528,957
- Daniel Bernstein$12,897,102
- Mark Mercola$44,191,191
- Nazish Sayed$4,856,076
Others in their field
Other Emerging Leaders on “Allogenic”
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
- Geoffrey Roger Hill · Fred Hutchinson Cancer Center$12,837,112
- Elizabeth Holly Payne · The Emmes Company, Llc$5,133,237
- Pietro Genovese · Dana-Farber Cancer Inst$4,879,104
- Sumithira Vasu · Ohio State University$4,852,591
Research focus
AllogenicAngiotensin-Converting Enzyme InhibitorsAnimal ModelAnthracyclinesBaseCardiacCardiac MyocytesCardiomyopathiesCardiotoxicityCardiovascular SystemCell Culture TechniquesCellsCell TherapyCessation Of LifeChemokineChemotherapyClinical TrialsCoculture TechniquesControlled Clinical TrialsCytokineData Coordinating CenterDouble-Blind MethodDoxorubicinAdrenergic Beta-Antagonists
Grant awards (2)
Using Exosomes to Preserve Viability and Function in Anthracycline Induced Cardiomyopathy Patient Specific Cardiomyocytes After Exposure to Doxorubicin$62,584
F32 · FY2018 · HL · contact PI
Using Exosomes to Preserve Viability and Function in Anthracycline Induced Cardiomyopathy Patient Specific Cardiomyocytes After Exposure to Doxorubicin$63,078
F32 · FY2017 · HL · contact PI